A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. - Puduvalli VK; Wu J; Yuan Y; Armstrong TS; Vera E; Xu J; Giglio P; Colman H; Walbert T; Raizer J; Groves MD; Tran D; et al. (Neuro-oncology, 2020)